Section Arrow
ANIK.NASDAQ
- Anika Therapeutics
Quotes are at least 15-min delayed:2026/06/28 01:37 EDT
Regular Hours
Last
 15.1
+0.48 (+3.28%)
Day High 
15.16 
Prev. Close
14.62 
1-M High
15.79 
Volume 
166.38K 
Bid
9.1
Ask
17.4
Day Low
14.58 
Open
14.58 
1-M Low
13.77 
Market Cap 
194.53M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 14.51 
20-SMA 14.57 
50-SMA 14.79 
52-W High 16.24 
52-W Low 7.8701 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.79/0.46
Enterprise Value
218.72M
Balance Sheet
Book Value Per Share
10.06
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
112.82M
Operating Revenue Per Share
12.27
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc4.02+0.24+6.35%37.8PE
PRGOPerrigo Company PLC9.95+0.27+2.79%-- 
HIMSHims & Hers Health33.94+1.23+3.76%-- 
UPCUniverse Pharmaceuticals Inc2.96+0.12+4.23%-- 
ZTSZOETIS76.09-1.73-2.22%12.76PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.